Table 2.
Laboratory test results
| Routine Lab | Recovery (n = 37) | Deterioration (n = 11) | P |
|---|---|---|---|
| WBC, ×109/L | 15.5 (12.0) | 11.9 (7.3) | 0.354 |
| Platelet, ×109/L | 188.0 [111.5, 322.5] | 96.0 [42.0, 169.0] | 0.012 |
| Neutrophil, ×109/L | 80.4 [70.0, 88.2] | 79.1 [69.1, 91.5] | 0.844 |
| Lymphocyte, ×109/L | 10.9 [6.5, 20.2] | 12.4 [4.4, 21.7] | 0.713 |
| CD3+ T cell, cells/µL | 1078.0 [398.8, 1195.4] | 371.8 [147.7, 544.4] | 0.022 |
| CD4+ T cell, cells/µL | 562.9 [216.3, 681.9] | 166.8 [71.9, 289.9] | 0.004 |
| CD8+ T cell, cells/µL | 355.1 [162.0, 469.5] | 179.5 [90.3, 252.4] | 0.020 |
| CD19+ T cell, cells/µL | 486.9 [173.9, 660.0] | 394.2 [98.5, 497.3] | 0.144 |
| CRP, mg/L | 86.3 (45.6) | 88.5 (55.9) | 0.894 |
| PCT, mg/L | 7.9 [0.9, 42.1] | 10.0 [4.2, 28.3] | 0.677 |
| Lactate, mmol/L | 1.1 [0.9, 1.8] | 2.6 [0.7, 7.8] | 0.102 |
| IL-6, pg/mL | 286.7 [53.7, 605.2] | 357.6 [69.8, 887.8] | 0.548 |
| Total bilirubin, µmol/L | 6.6 [4.9, 12.0] | 17.2 [6.8, 93.0] | 0.019 |
| ALT, U/L | 17.6 [10.9, 29.7] | 54.0 [20.0, 421.5] | 0.008 |
| AST, U/L | 39.3 [23.4, 61.8] | 328.0 [44.7, 827.3] | 0.002 |
| D-dimers, µg/mL | 2.6 [1.4, 7.1] | 5.7 [2.7, 17.7] | 0.079 |
| Blood glucose, mmol/L | 6.7 [5.4, 7.7] | 8.4 [6.1, 11.3] | 0.062 |
| Vasoactive drugs | 13 (35.1) | 10 (90.9) | 0.001 |
Data are presented as median [interquartile range], mean (SD) or n (%). WBC, white blood cell; CRP, c-reactive protein; PCT, procaicitonin; IL-6, interleukin-6; ALT, alanine aminotransferase; AST, aspartate aminotransferase